Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Long-term Follow-Up of Participants of the Phase II Study That Evaluated Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis (ASSET Trial) Sarsam, N., Johnson, S. R., Chung, L., Kafaja, S., Pope, J., Domsic, R., Mayes, M., Sandorfi, N., Steen, V., Castelino, F., Hant, F., Huang, S., Khanna, D. WILEY. 2022: 3009-3011
View details for Web of Science ID 000877386504021